Publication | Closed Access

Comparison of effects of losartan, irbesartan, and candesartan on flow-mediated brachial artery dilation and on inflammatory and thrombolytic markers in patients with systemic hypertension

ThrombosisHypertensionCardiovascular DiseaseMedicineAntihypertensive TherapyVascular PharmacologyCardiovascular PharmacologyVascular BiologyThrombolytic MarkersPharmacologyAtherosclerosisAnesthesiologySystemic Hypertension